Subtype
Intermediate Soft Tissue Neoplasm
CI-CAN-00001021Explore in graph →
Non-malignant32 active trials42 evidence items
- NCIt
- C7653
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001021Explore in graph →
Clinical trials
136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04448873 | Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma | completed | Phase 4 | 30 | Children's Hospital of Fudan UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT04077515 | Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma | completed | Phase 4 | 92 | Children's Hospital of Fudan UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT02647619 | Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF | completed | Phase 4 | 80 | University Hospital, AkershusOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT01265420 | Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb | completed | Phase 4 | 7 | Indiana Hand to Shoulder CenterOTHER | 1 | Apr 30, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Sep 26, 2023source: clinicaltrials